Elizabeth O. Beale, MD
Founder, CEO, and inventor of the Alsteni System. Board-certified endocrinologist with 30+ years of clinical practice. Lead inventor on U.S. Patents 12,599,544 and 10,744,070. Principal Investigator on the first-in-human feasibility trial published in Nutrition & Diabetes (Springer Nature, 2020).
Board-certified by the American Board of Internal Medicine in Internal Medicine, Endocrinology/Diabetes/Metabolism, Obesity Medicine, and Lifestyle Medicine. MRCP (UK). MD, University of Adelaide.
Former Associate Professor of Clinical Medicine, USC Keck School of Medicine. 45+ peer-reviewed publications across endocrinology, metabolic medicine, and gut hormone physiology.
Lead inventor on U.S. Patent 12,599,544, "Intraoral Gastrointestinal Access Device and Related Methods," issued April 14, 2026. Lead inventor on U.S. Patent 10,744,070 (issued, through 2039). Inventor of the Alsteni System — an intraorally-anchored, patient-removable enteral feeding platform.
Principal Investigator on the first-in-human feasibility trial of intraorally-anchored enteral nutrition, published in Nutrition & Diabetes (Springer Nature, 2020). Co-author with Prof. Michael Horowitz, AO (University of Adelaide) on the hypothesis paper establishing the scientific rationale for bolus enteral nutrient delivery (Nutrition, 2022).